Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 4
1991 2
1992 5
1993 2
1994 3
1995 8
1996 8
1997 5
1998 13
1999 12
2000 9
2001 22
2002 12
2003 18
2004 21
2005 23
2006 8
2007 12
2008 24
2009 35
2010 41
2011 37
2012 36
2013 30
2014 21
2015 19
2016 22
2017 15
2018 20
2019 12
2020 5
2021 7
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

485 results
Results by year
Filters applied: . Clear all
Page 1
Whole genome sequencing of Mycobacterium tuberculosis: current standards and open issues.
Meehan CJ, Goig GA, Kohl TA, Verboven L, Dippenaar A, Ezewudo M, Farhat MR, Guthrie JL, Laukens K, Miotto P, Ofori-Anyinam B, Dreyer V, Supply P, Suresh A, Utpatel C, van Soolingen D, Zhou Y, Ashton PM, Brites D, Cabibbe AM, de Jong BC, de Vos M, Menardo F, Gagneux S, Gao Q, Heupink TH, Liu Q, Loiseau C, Rigouts L, Rodwell TC, Tagliani E, Walker TM, Warren RM, Zhao Y, Zignol M, Schito M, Gardy J, Cirillo DM, Niemann S, Comas I, Van Rie A. Meehan CJ, et al. Among authors: van soolingen d. Nat Rev Microbiol. 2019 Sep;17(9):533-545. doi: 10.1038/s41579-019-0214-5. Nat Rev Microbiol. 2019. PMID: 31209399 Review.
Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.
CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C, Arandjelovic I, Bi L, Beckert P, Bonnet M, Bradley P, Cabibbe AM, Cancino-Muñoz I, Caulfield MJ, Chaiprasert A, Cirillo DM, Clifton DA, Comas I, Crook DW, De Filippo MR, de Neeling H, Diel R, Drobniewski FA, Faksri K, Farhat MR, Fleming J, Fowler P, Fowler TA, Gao Q, Gardy J, Gascoyne-Binzi D, Gibertoni-Cruz AL, Gil-Brusola A, Golubchik T, Gonzalo X, Grandjean L, He G, Guthrie JL, Hoosdally S, Hunt M, Iqbal Z, Ismail N, Johnston J, Khanzada FM, Khor CC, Kohl TA, Kong C, Lipworth S, Liu Q, Maphalala G, Martinez E, Mathys V, Merker M, Miotto P, Mistry N, Moore DAJ, Murray M, Niemann S, Omar SV, Ong RT, Peto TEA, Posey JE, Prammananan T, Pym A, Rodrigues C, Rodrigues M, Rodwell T, Rossolini GM, Sánchez Padilla E, Schito M, Shen X, Shendure J, Sintchenko V, Sloutsky A, Smith EG, Snyder M, Soetaert K, Starks AM, Supply P, Suriyapol P, Tahseen S, Tang P, Teo YY, Thuong TNT, Thwaites G, Tortoli E, van Soolingen D, Walker AS, Walker TM, Wilcox M, Wilson DJ, Wyllie D, Yang Y, Zhang H, Zhao Y, Zhu B. CRyPTIC Consortium and the 100,000 Genomes Project, et al. Among authors: van soolingen d. N Engl J Med. 2018 Oct 11;379(15):1403-1415. doi: 10.1056/NEJMoa1800474. Epub 2018 Sep 26. N Engl J Med. 2018. PMID: 30280646 Free PMC article.
XDR tuberculosis.
van Ingen J, de Lange WC, Boeree MJ, Iseman MD, Daley CL, Heifets LB, Böttger EC, van Soolingen D. van Ingen J, et al. Among authors: van soolingen d. Lancet Infect Dis. 2011 Aug;11(8):585. doi: 10.1016/S1473-3099(11)70200-6. Lancet Infect Dis. 2011. PMID: 21798459 No abstract available.
[Nontuberculous mycobacteria: clinically relevant].
van Ingen J, Hoefsloot W, de Lange WC, Magis-Escurra C, Dekhuijzen PN, Boeree MJ, van Soolingen D. van Ingen J, et al. Among authors: van soolingen d. Ned Tijdschr Geneeskd. 2010;154:A1178. Ned Tijdschr Geneeskd. 2010. PMID: 20482903 Review. Dutch.
Should treatment of low-level mono-resistant tuberculosis be different?
Gopie FA, Commiesie E, de Lange WCM, van Soolingen D, Vreden SGS, de Vries G. Gopie FA, et al. Among authors: van soolingen d. J Clin Tuberc Other Mycobact Dis. 2021 Apr 30;23:100241. doi: 10.1016/j.jctube.2021.100241. eCollection 2021 May. J Clin Tuberc Other Mycobact Dis. 2021. PMID: 34095547 Free PMC article. No abstract available.
Laboratory-acquired tuberculosis.
Peerbooms PG, van Doornum GJ, van Deutekom H, Coutinho RA, van Soolingen D. Peerbooms PG, et al. Among authors: van soolingen d. Lancet. 1995 May 20;345(8960):1311-2. doi: 10.1016/s0140-6736(95)90962-1. Lancet. 1995. PMID: 7746083 No abstract available.
Measuring tuberculosis transmission in low-incidence countries.
de Vries G, van Dissel J, van Soolingen D. de Vries G, et al. Among authors: van soolingen d. Lancet Respir Med. 2018 Apr;6(4):e13. doi: 10.1016/S2213-2600(18)30042-0. Epub 2018 Feb 2. Lancet Respir Med. 2018. PMID: 29398474 No abstract available.
Nontuberculous mycobacteria, zambia.
Buijtels PC, van-der-Sande MA, de-Graaff CS, Parkinson S, Verbrugh HA, Petit PL, van-Soolingen D. Buijtels PC, et al. Among authors: van soolingen d. Emerg Infect Dis. 2009 Feb;15(2):242-9. doi: 10.3201/eid1502.080006. Emerg Infect Dis. 2009. PMID: 19193268 Free PMC article.
485 results